Blier P - Search Results

1

Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function.

Santarelli L, Gobbi G, Debs PC, Sibille ET, Blier P, Hen R, Heath MJ. Santarelli L, et al. Among authors: blier p. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1912-7. doi: 10.1073/pnas.98.4.1912. Epub 2001 Jan 30. Proc Natl Acad Sci U S A. 2001. PMID: 11172050 Free PMC article.

2

Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1).

Santarelli L, Gobbi G, Blier P, Hen R. Santarelli L, et al. Among authors: blier p. J Clin Psychiatry. 2002;63 Suppl 11:11-7. J Clin Psychiatry. 2002. PMID: 12562138 Review.

3

Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.

Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ, Brunner D, Hen R. Ramboz S, et al. Among authors: blier p. Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14476-81. doi: 10.1073/pnas.95.24.14476. Proc Natl Acad Sci U S A. 1998. PMID: 9826725 Free PMC article.

4

Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugs.

Gobbi G, Blier P. Gobbi G, et al. Among authors: blier p. Peptides. 2005 Aug;26(8):1383-93. doi: 10.1016/j.peptides.2005.03.032. Epub 2005 Apr 21. Peptides. 2005. PMID: 16042978 Review.

5

Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function.

Gobbi G, Cassano T, Radja F, Morgese MG, Cuomo V, Santarelli L, Hen R, Blier P. Gobbi G, et al. Among authors: blier p. Eur Neuropsychopharmacol. 2007 Apr;17(5):328-38. doi: 10.1016/j.euroneuro.2006.07.004. Epub 2006 Sep 6. Eur Neuropsychopharmacol. 2007. PMID: 16950604

6

Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study.

Gobbi G, Murphy DL, Lesch K, Blier P. Gobbi G, et al. Among authors: blier p. J Pharmacol Exp Ther. 2001 Mar;296(3):987-95. J Pharmacol Exp Ther. 2001. PMID: 11181933

7

Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response.

Blier P, Gobbi G, Haddjeri N, Santarelli L, Mathew G, Hen R. Blier P, et al. J Psychiatry Neurosci. 2004 May;29(3):208-18. J Psychiatry Neurosci. 2004. PMID: 15173897 Free PMC article.

8

Modification of serotonin neuron properties in mice lacking 5-HT1A receptors.

Richer M, Hen R, Blier P. Richer M, et al. Among authors: blier p. Eur J Pharmacol. 2002 Jan 25;435(2-3):195-203. doi: 10.1016/s0014-2999(01)01607-7. Eur J Pharmacol. 2002. PMID: 11821026

9

Regulation of [3H]5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knock-out mice.

Piñeyro G, Castanon N, Hen R, Blier P. Piñeyro G, et al. Among authors: blier p. Neuroreport. 1995 Dec 29;7(1):353-9. Neuroreport. 1995. PMID: 8742487

10

Neurochemical and psychotropic effects of bupropion in healthy male subjects.

Gobbi G, Slater S, Boucher N, Debonnel G, Blier P. Gobbi G, et al. Among authors: blier p. J Clin Psychopharmacol. 2003 Jun;23(3):233-9. doi: 10.1097/01.jcp.0000084023.22282.03. J Clin Psychopharmacol. 2003. PMID: 12826985 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters